Insider · CIK 0001920738
Scott Bizily
Files at FDMT (4D Molecular Therapeutics, Inc.). First filing Sep 26, 2025, latest Sep 22, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FDMT: 4D Molecular Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | 4D Molecular Therapeutics, Inc. | $22k 1,635 shares | -16% | - | |
| 0Weak | 4D Molecular Therapeutics, Inc. | $8,176 584 shares | -6% | - | |
| 0Weak | 4D Molecular Therapeutics, Inc. | $19k 2,407 shares | -24% | +203% from low-34% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | FDMT 4D Molecular Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +1,635 | $4.14 | $6,769 | 10,252 | 20 d ago |
| Sep 16, 2026 | FDMT 4D Molecular Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,635 | $13.65 | $22k | 8,617 | 20 d ago |
| Sep 16, 2026 | FDMT 4D Molecular Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,635 | $0.00 | $0 | 58,066 | 20 d ago |
| Sep 1, 2026 | FDMT 4D Molecular Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +584 | $6.49 | $3,790 | 9,201 | 39 d ago |
| Sep 1, 2026 | FDMT 4D Molecular Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -584 | $14.00 | $8,176 | 8,617 | 39 d ago |
| Sep 1, 2026 | FDMT 4D Molecular Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -584 | $0.00 | $0 | 2,959 | 39 d ago |
| Sep 23, 2025 | FDMT 4D Molecular Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,407 | $8.00 | $19k | 7,596 | Sep 26, 2025 |
| Mar 6, 2025 | FDMT 4D Molecular Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +78,500 | $0.00 | $0 | 78,500 | Mar 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.